2
Participants
Start Date
September 11, 2023
Primary Completion Date
January 22, 2024
Study Completion Date
December 31, 2025
Surgical removal of the GBM tumor
Surgical removal of the GBM tumor
d4-NAM infusion
Following the surgical removal of the GBM tumor, GBM patients will be dosed with a form of nicotinamide (a natural vitamin) that we can track. The nicotinamide will be converted to methyl nicotinamide (MeNAM) in the tumor. We will measure how fast the nicotinamide is converted to methyl nicotinamide. We believe that the speed of this chemical reaction in the tumor (fast versus slow) may be correlated with GBM aggressiveness.
AdventHealth Translational Research Institute, Orlando
AdventHealth Translational Research Institute
OTHER